Earlier versus delayed ruxolitinib treatment for patients with myelofibrosis: a plain language summary.
- DOI
- 10.1080/14796694.2024.2440255
- Published
- 2025 Mar
- Container
- Future oncology (London, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/14796694.2024.2440255,
title = {Earlier versus delayed ruxolitinib treatment for patients with myelofibrosis: a plain language summary.},
author = {Harrison C and Kiladjian JJ and Vannucchi AM and Mesa RA},
year = {2025},
journal = {Future oncology (London, England)},
doi = {10.1080/14796694.2024.2440255},
url = {https://doi.org/10.1080/14796694.2024.2440255}
}RIS
TY - JOUR TI - Earlier versus delayed ruxolitinib treatment for patients with myelofibrosis: a plain language summary. AU - Harrison C AU - Kiladjian JJ AU - Vannucchi AM AU - Mesa RA PY - 2025 JO - Future oncology (London, England) DO - 10.1080/14796694.2024.2440255 UR - https://doi.org/10.1080/14796694.2024.2440255 ER -
APA
C, H., JJ, K., AM, V., & RA, M. (2025). Earlier versus delayed ruxolitinib treatment for patients with myelofibrosis: a plain language summary.. Future oncology (London, England). https://doi.org/10.1080/14796694.2024.2440255
Source records
- pubmed · retrieved 2026-09-26T12:59:09.483Z